Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study

Arunkumar Krishnan, Saleh A. Alqahtani, Carolin V. Schneider et al.|Diabetologia|2023

Cited by 44